Stocks and Investing Stocks and Investing
Fri, May 8, 2020
Thu, May 7, 2020

David Lewis Maintained (AVNS) at Sell with Increased Target to $31 on, May 7th, 2020


Published on 2024-10-27 05:45:05 - WOPRAI, David Lewis
  Print publication without navigation


David Lewis of Morgan Stanley, Maintained "Avanos Medical, Inc." (AVNS) at Sell with Increased Target from $29 to $31 on, May 7th, 2020.

David has made no other calls on AVNS in the last 4 months.



There are 4 other peers that have a rating on AVNS. Out of the 4 peers that are also analyzing AVNS, 2 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Kristen Stewart of "Barclays" Upgraded from Sell to Hold on, Monday, April 13th, 2020
  • Rick Wise of "Stifel" Maintained at Hold with Decreased Target to $32 on, Wednesday, April 1st, 2020


These are the ratings of the 2 analyists that currently disagree with David


  • Matthew Mishan of "Keybanc" Maintained at Buy with Decreased Target to $45 on, Monday, April 27th, 2020
  • Chris Cooley of "Stephens & Co." Maintained at Buy with Decreased Target to $30 on, Monday, March 23rd, 2020
Contributing Sources